Cao Danming, Zou Rong, Zhang Ming, Tang Kui
Department of Ultrasound Diagnosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Research Center of Ultrasonography, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Thyroid Res. 2024 Oct 1;17(1):20. doi: 10.1186/s13044-024-00208-5.
To investigate the sonographic characteristics of thyroid nodules with a halo, explore the value of contrast-enhanced ultrasound (CEUS) combined with fine needle aspiration (FNA) in identifying nodules with a halo, and predict the risk of metastasis by analyzing the pathological features of the halo.
A retrospective analysis was conducted on 185 postoperative cases of thyroid nodules accompanied by halos between January 2019 and December 2022. After describing the ultrasound characteristics of the thyroid nodules and their halos, all patients were divided into three groups, the first group (group I = CEUS only) of patients underwent CEUS, the second group (group II = CEUS + FNA) underwent FNA based on the first group, and the third group (group III = FNA only) underwent FNA directly. The CEUS and FNA results were graded using the Chinese Thyroid Imaging Report and Data System (C-TIRADS) and Bethesda Reporting System for Thyroid Cytopathology, respectively. Those graded below C-TIRADS 4b or Bethesda IV were defined as benign, and the results of FNA were referenced when the two methods were combined. The surgical pathology results were used as the gold standard. We plotted working curves to compare the diagnostic efficacy of CEUS and FNA alone and in combination in the diagnosis of thyroid nodules with halos. The pathological features of the halo were analyzed and the number of patients with cervical lymph node metastases was recorded.
One hundred and sixty patients met the requirements. Benign nodules were mainly characterized by a thin (0.75 ± 0.31 mm) and uniform halo with good integrity, while malignant nodules had a thicker (1.48 ± 0.51 mm) halo with uneven and irregular margins (P < 0.05). The sensitivity and specificity were highest when the cutoff value was 1.09 mm, with 76.08% and 84.29%, respectively. The halos of benign nodules were mostly hyper- or iso-enhanced, whereas the halos of malignant nodules were predominantly hypo-enhanced (P < 0.05). The areas under the curve (AUCs) for CEUS, FNA, and CEUS + FNA were 0.751(95% CI = 0.642-0.841), 0.863(95% CI = 0.767-0.929), and 0.918(95% CI = 0.834-0.967), respectively. Cervical lymph node metastasis occurred in only 13 (11.5%) malignant nodes with halos. The primary pathological components of the halo around malignant nodules were almost reactive hyperplastic fibrous tissue.
The halo surrounding malignant thyroid nodules is thicker, with uneven and irregular margins, and shows hypo-enhancement on CEUS. Combining CEUS with FNA improves the diagnostic efficacy of thyroid nodules with halos. The reactive hyperplastic fibrous halo may be one of the reasons why malignant nodules are less likely to metastasize.
探讨有晕环甲状腺结节的超声特征,探讨超声造影(CEUS)联合细针穿刺抽吸活检(FNA)在鉴别有晕环结节中的价值,并通过分析晕环的病理特征预测转移风险。
回顾性分析2019年1月至2022年12月期间185例术后伴有晕环的甲状腺结节病例。在描述甲状腺结节及其晕环的超声特征后,将所有患者分为三组,第一组(I组=仅行CEUS)患者接受CEUS检查,第二组(II组=CEUS+FNA)在第一组基础上接受FNA检查,第三组(III组=仅行FNA)直接接受FNA检查。CEUS和FNA结果分别采用中国甲状腺影像报告和数据系统(C-TIRADS)及甲状腺细胞病理学贝塞斯达报告系统进行分级。C-TIRADS 4b级以下或贝塞斯达IV级以下定义为良性,两种方法联合时参考FNA结果。手术病理结果作为金标准。绘制工作曲线比较CEUS、FNA单独及联合诊断有晕环甲状腺结节的诊断效能。分析晕环的病理特征并记录颈部淋巴结转移患者数量。
160例患者符合要求。良性结节主要表现为薄(0.75±0.31mm)且均匀的晕环,完整性好,而恶性结节晕环较厚(1.48±0.51mm),边缘不均匀且不规则(P<0.05)。截断值为1.09mm时,敏感性和特异性最高,分别为76.08%和84.29%。良性结节的晕环大多为高增强或等增强,而恶性结节的晕环主要为低增强(P<0.05)。CEUS、FNA及CEUS+FNA的曲线下面积(AUC)分别为0.751(95%CI=0.642-0.841)、0.863(95%CI=0.767-0.929)和0.918(95%CI=0.834-0.967)。仅13个(11.5%)有晕环的恶性结节发生颈部淋巴结转移。恶性结节周围晕环的主要病理成分几乎均为反应性增生性纤维组织。
恶性甲状腺结节周围的晕环较厚,边缘不均匀且不规则,CEUS表现为低增强。CEUS与FNA联合可提高有晕环甲状腺结节的诊断效能。反应性增生性纤维晕环可能是恶性结节转移可能性较小的原因之一。